Research trends in brain imaging of mild cognitive impairment in 25 years: a bibliometric analysis

Main Article Content

Daniella Satyasari
Agnes Tineke Waney Rorong


Mild cognitive impairment (MCI) is a condition that is experienced by most elderly in the world. Although there has been a huge rise in research on developing brain imaging tests that can identify and evaluate MCI early on, a bibliometric analysis of this issue is still lacking. The purpose of this review is to determine the pattern and growth of research trends related to MCI and brain imaging using bibliometric analysis, based on Scopus data from 1996 to 2021. The data was converted to Comma Separated Values (CSV) and exported to VOSviewer to bibliometrically analyze the origin by country, keywords, frequently cited articles, author, and journals. Over a 25-year period, 5081 articles were discovered, with the number rising, particularly in the past four years, and significantly in 2022 when 561 articles (11.04%) were found. The Journal of Alzheimer's Disease (19.22%) and Neuroimage Clinical (10.22%) published the largest number of articles on this subject. The United States (24.31%) led all other countries in the number of publications, followed by China (14.84%) and UK (6.5%). The most cited article was by Petersen RC in 1999 (41 citations) about MCI and its clinical characterization. The keywords that appeared the most frequently were mild cognitive impairment (984 occurrences) associated with biomarkers, brain scanning procedures, brain part, age, and human subject. The most frequently cited authors were Petersen RC (1365 citations) and Jack CR (1103 citations). Neuroimage (4164 citations), and Neurology (3268 citations) are the most repeatedly cited journals. This bibliometric study displays the trend in the last 25 years for MCI and brain imaging.

Article Details

How to Cite
Satyasari, D., & Rorong, A. T. W. . (2023). Research trends in brain imaging of mild cognitive impairment in 25 years: a bibliometric analysis. Universa Medicina, 42(2), 214–226.
Review Article


World Health Organization. World report on ageing and health. Geneva: WHO; 2015.

Hugo J, Ganguli M. Dementia and cognitive impairment. Clin Geriatr Med 2014 ;30:421–42. doi: 10.1016/j.cger.2014.04.001.

Baumgart M, Snyder HM, Carrillo MC, Fazio S, Kim H, Johns H. Summary of the evidence on modifiable risk factors for cognitive decline and dementia: a population based perspective. Alzheimers Dement 2015;11:718–26. doiI: 10.1016/j.jalz.2015.05.016.

Direktorat Statistik Kesejahteraan Rakyat. Statistik Penduduk Lanjut Usia. Jakarta: Badan Pusat Statistik; 2022.

Akhmad A, Sahmad S, Hadi I, Rosyanti L. Mild cognitive impairment (MCI) pada aspek kognitif dan tingkat kemandirian lansia dengan mini-mental state examination (MMSE). Health Inf J Penelit 2019;11:48–58. doi: 10.36990/hijp.v11i1.105.

Livingston G, Sommerlad A, Orgeta V, et al. Dementia prevention, intervention, and care. Lancet 2017;390:2673–734. doi: 10.1016/S0140-6736(17)31363-6.

Chien DT, Bahri S, Szardenings AK, et al. Early clinical PET imaging results with the novel PHF-Tau Radioligand [F-18]-T807. J Alzheimers Dis 2013;34:457–68. doi: 10.3233/JAD-122059.

Fleisher AS, Chen K, Quiroz YT, et al. Associations between biomarkers and age in the presenilin 1 E280A autosomal dominant Alzheimer disease kindred: a cross-sectional study. JAMA Neurol 2015;72:316. doi: 10.1001/jamaneurol.2014.3314.

Xia MH, Li A, Gao RX, et al. Research hotspots and trends of multimodality MRI on vascular cognitive impairment in recent 12 years: a bibliometric analysis. Medicine (Baltimore) 2022;101:e30172. DOI: 10.1097/MD.0000000000030172.

Herrera-Franco G, Montalván-Burbano N, Carrión-Mero P, Jaya-Montalvo M, Gurumendi-Noriega M. Worldwide research on geoparks through bibliometric analysis. Sustainability 2021;13:1175. doi: 10.3390/su13031175.

Cancino CA, Merigo JM, Coronado FC. Big names in innovation research: a bibliometric overview. Curr Sci 2017;113:1507. doi: 10.18520/cs/v113/i08/1507-1518.

van Eck NJ, Waltman L. Visualizing bibliometric networks. In: Ding Y, Rousseau R, Wolfram D, editors. Measuring scholarly impact. Cham (Switzerland): Springer International Publishing; 2014.p. 285–320.

Ronoatmojo IS, Apriniyadi M, Nugraheni RD, Riyandhani CP, Rosyidan CR, Sutadiwiria Y. Bibliometric analysis on numerical lithofacies identification for reservoir characterization in the period of 1980 - 2021. J Petro 2022;XI:163–72. doi: 10.25105/petro.v11i4.14424.

Casprini E, Dabic M, Kotlar J, Pucci T. A bibliometric analysis of family firm internationalization research: current themes, theoretical roots, and ways forward. Int Bus Rev 2020;29:101715. doi: 10.1016/j.ibusrev.2020.101715.

Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999;56:303–8. doi: 10.1001/archneur.56.3.303.

Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med 2004;256:183–94. doi: 10.1111/j.1365-2796.2004.01388.x.

Tzourio-Mazoyer N, Landeau B, Papathanassiou D, et al. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 2002;15:273–89. doi: 10.1006/nimg.2001.0978.

Albert MS, DeKosky ST, Dickson D, et al. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 2011;7:270–9. doi: 10.1016/j.jalz.2011.03.008.

Fischl B. FreeSurfer. Neuroimage 2012;62:774–81. doi: 10.1016/j.neuroimage.2012.01.021.

Rathore S, Habes M, Iftikhar MA, Shacklett A, Davatzikos C. A review on neuroimaging-based classification studies and associated feature extraction methods for Alzheimer’s disease and its prodromal stages. Neuroimage 2017;155:530–48. doi: 10.1016/j.neuroimage.2017.03.057.

Sperling RA, Aisen PS, Beckett LA, et al. Toward defining the preclinical stages of Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 2011;7:280–92. doi: 10.1016/j.jalz.2011.03.003.

Belleville S, Gauthier S, Lepage E, Kergoat MJ, Gilbert B. Predicting decline in mild cognitive impairment: a prospective cognitive study. Neuropsychology 2014;28:643–52. doi: 10.1037/neu0000063.

Dubois B, Feldman HH, Jacova C, et al. Advancing research diagnostic criteria for Alzheimer’s disease: the IWG-2 criteria. Lancet Neurol 2014;13:614–29. doi: 10.1016/S1474-4422(14)70090-0.

Besson FL, La Joie R, Doeuvre L, et al. Cognitive and brain profiles associated with current neuroimaging biomarkers of preclinical Alzheimer’s disease. J Neurosci 2015 ;35:10402–11. doi: 10.1523/JNEUROSCI.0150-15.2015.

Mejia C, Wu M, Zhang Y, Kajikawa Y. Exploring topics in bibliometric research through citation networks and semantic analysis. Front Res Metr Anal 2021;6:742311. doi: 10.3389/frma.2021.742311.

Li XL, Gao RX, Zhang Q, et al. A bibliometric analysis of neuroimaging biomarkers in Parkinson disease based on Web of Science. Medicine (Baltimore) 2022;101:e30079. doi: 10.1097/MD.0000000000030079.

Vipin A, Satish V, Saffari SE, et al. Dementia in Southeast Asia: influence of onset-type, education, and cerebrovascular disease. Alzheimers Res Ther 2021;13:195. doi: 10.1186/s13195-021-00936-y.

Hilal S, Mok V, Youn YC, Wong A, Ikram MK, Chen CLH. Prevalence, risk factors and consequences of cerebral small vessel diseases: data fom three Asian countries. J Neurol Neurosurg Psychiatry 2017;88:669–74. doi: 10.1136/jnnp-2016-315324.

Potashman M, Gillis J, Mirzaei F, Maserejian N. PND21 - the prevalence of mild cognitive impairment: a systematic review and data synthesis. Value Health 2018;21:S332–3. doi: 10.1016/j.jval.2018.09.198.8

Porsteinsson AP, Isaacson RS, Knox S, Sabbagh MN, Rubino I. Diagnosis of early Alzheimer’s disease: clinical practice in 2021. J Prev Alzheimers Dis 2021;1–16. doi: 10.14283/jpad.2021.23.

Sachdev PS, Lo JW, Crawford JD, et al. STROKOG (stroke and cognition consortium): An international consortium to examine the epidemiology, diagnosis, and treatment of neurocognitive disorders in relation to cerebrovascular disease. Alzheimers Dement Amst Neth 2017;7:11–23. doi: 10.1016/j.dadm.2016.10.006.

Deng Y, Zhao S, Cheng G, et al. The prevalence of mild cognitive impairment among Chinese people: a meta-analysis. Neuroepidemiology 2021;55:79–91. doi: 10.1159/000512597.

Hussin NM, Shahar S, Yahya HM, Din NC, Singh DKA, Omar MA. Incidence and predictors of mild cognitive impairment (MCI) within a multi-ethnic Asian populace: a community-based longitudinal study. BMC Public Health 2019;19:1159. doi: 10.1186/s12889-019-7508-4.

Sachdev PS, Lipnicki DM, Kochan NA, et al. The prevalence of mild cognitive impairment in diverse geographical and ethnocultural regions: the COSMIC Collaboration. PLoS One 2015;10:e0142388. doi: 10.1371/journal.pone.0142388.

Lu Y, Liu C, Yu D, et al. Prevalence of mild cognitive impairment in community-dwelling Chinese populations aged over 55 years: a meta-analysis and systematic review. BMC Geriatr 2021;21:10. doi: 10.1186/s12877-020-01948-3.

Ishikawa KM, Davis J, Chen JJ, Lim E. The prevalence of mild cognitive impairment by aspects of social isolation. PLoS One 2022;17:e0269795. doi: 10.1371/journal.pone.0269795.

Teh WL, Abdin E, Vaingankar JA, et al. Prevalence, lifestyle correlates, and psychosocial functioning among multi-ethnic older adults with mild cognitive impairment in Singapore: preliminary findings from a 10/66 Population Study. Yale J Biol Med 2021;94:73–83.

Patro SN, Glikstein R, Hanagandi P, Chakraborty S. Role of neuroimaging in multidisciplinary approach towards non-Alzheimer’s dementia. Insights Imaging 2015;6:531–44. doi: 10.1007/s13244-015-0421-1.

Zucchella C, Sinforiani E, Tamburin S, et al. The multidisciplinary approach to Alzheimer’s disease and dementia: a narrative review of non-pharmacological treatment. Front Neurol ;9:1058. doi: 10.3389/fneur.2018.01058.

Blackman J, Swirski M, Clynes J, Harding S, Leng Y, Coulthard E. Pharmacological and non pharmacological interventions to enhance sleep in mild cognitive impairment and mild Alzheimer’s disease: a systematic review. J Sleep Res 2021;4: e13229. doi: 10.1111/jsr.13229..

Fink HA, Jutkowitz E, McCarten JR, et al. Pharmacologic interventions to prevent cognitive decline, mild cognitive impairment, and clinical Alzheimer-type dementia: a systematic review. Ann Intern Med 2018;168:39. doi: 10.7326/M17-1529.

Lee GE, Kim JY, Jung JH, Kang HW, Jung IC. Non-pharmacological interventions for patients with dementia: a protocol for a systematic review and meta-analysis. Medicine (Baltimore). 2019;98:e17279. doi: 10.1097/MD.0000000000017279.

Galvin JE, Valois L, Zweig Y. Collaborative transdisciplinary team approach for dementia care. Neurodegener Dis Manag 2014;4:455–69. doi: 10.2217/nmt.14.47.

Heintz H, Monette P, Epstein-Lubow G, Smith L, Rowlett S, Forester BP. Emerging collaborative care models for dementia care in the primary care setting: a narrative review. Am J Geriatr Psychiatry 2020;28:320–30. doi: 10.1016/j.jagp.2019.07.015.

Nieuwboer MS, Richters A, van der Marck MA. Triple aim improvement for individuals, services and society in dementia care: the dementianet collaborative care approach. Z Gerontol Geriatr 2017;50(Suppl 2):78–83. doi: 10.1007/s00391-017-1196-4.

Samus QM, Black BS, Bovenkamp D, et al. Home is where the future is: the BrightFocus Foundation consensus panel on dementia care. Alzheimers Dement 2018;14:104–14. doi: 10.1016/j.jalz.2017.10.006.

Schindler SE. Fluid biomarkers in dementia diagnosis. Contin Lifelong Learn Neurol 2022 ;28:822–33. doi: 10.1212/CON.0000000000001083.

Ruan Q, D’Onofrio G, Sancarlo D, Bao Z, Greco A, Yu Z. Potential neuroimaging biomarkers of pathologic brain changes in mild cognitive impairment and Alzheimer’s disease: a systematic review. BMC Geriatr 2016;16:104. doi: 10.1186/s12877-016-0281-7.

Petersen RC, Morris JC. Mild cognitive impairment as a clinical entity and treatment target. Arch Neurol 2005;62:1160–3; discussion 1167. doi: 10.1001/archneur.62.7.1160.

Petersen LE, Hammon J, McCormick J, Petersen RC. Cognitive aging research at Mayo Clinic. Minn Med 2002;85:29–31. doi: 10.1001/archneur.62.7.1160.

Petersen RC. New clinical criteria for the Alzheimer’s disease spectrum. Minn Med 2012;95:42–5.

Baker DJ, Petersen RC. Cellular senescence in brain aging and neurodegenerative diseases: evidence and perspectives. J Clin Inves. 2018 2;128:1208–16. doi: 10.1172/JCI95145.

Jack CR, Knopman DS, Jagust WJ, et al. Tracking pathophysiological processes in Alzheimer’s disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol 2013;12:207–16. doi: 10.1016/S1474-4422(12)70291-0.

Petersen RC, Lopez O, Armstrong MJ, et al. Practice guideline update summary: mild cognitive impairment: report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology 2018;90:126–35. doi: 10.1212/WNL.0000000000004826.

Petersen RC, Graf A, Carrillo MC, Weber CJ. Current understanding of AD pathophysiology and impact of amyloid-beta targeted treatments on biomarkers and clinical endpoints. Alzheimers Dement (NY) 2022;8:e12361. doi: 10.1002/trc2.12361

Nie D, Shen D. Adversarial confidence learning for medical image segmentation and synthesis. Int J Comput Vis 2020;128:2494–513. doi: 10.1007/s11263-020-01321-2.

Zhou T, Thung KH, Liu M, Shi F, Zhang C, Shen D. Multi-modal latent space inducing ensemble SVM classifier for early dementia diagnosis with neuroimaging data. Med Image Anal 2020;60:101630. doi: 10.1016/

Xue Z, Shen D, Davatzikos C. CLASSIC: consistent longitudinal alignment and segmentation for serial image computing. Inf Process Med Imaging 2005;19:101–13. doi: 10.1007/11505730_9.

Blennow K, Zetterberg H. Biomarkers for Alzheimer’s disease: current status and prospects for the future. J Intern Med 2018;284:643–63. doi: 10.1111/joim.12816.

Knopman DS, Petersen RC. Mild cognitive impairment and mild dementia: a clinical perspective. Mayo Clin Proc 2014;89:1452–9. doi: 10.1016/j.mayocp.2014.06.019.

Scheltens P, De Strooper B, Kivipelto M, et al. Alzheimer’s disease. Lancet 2021 ;397:1577–90. doi: 10.1016/S0140-6736(20)32205-4.

Klunk WE, Koeppe RA, Price JC, et al. The Centiloid project: standardizing quantitative amyloid plaque estimation by PET. Alzheimers Dement 2015;11:1-15.e1-4. doi: 10.1016/j.jalz.2014.07.003.

Aarsland D, Creese B, Politis M, et al. Cognitive decline in Parkinson disease. Nat Rev Neurol 2017;13:217–31. doi: 10.1038/nrneurol.2017.27.